Latest filing published 11 Jan 2024 for Newbury Pharmaceuticals AB, €313k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +22.1%Entry SEK 3.08 · Close at T+365 SEK 3.76
- -25.0%Entry SEK 6.20 · Close at T+365 SEK 4.65
- -8.2%Entry SEK 4.16 · Close at T+365 SEK 3.82
- -8.2%Entry SEK 4.16 · Close at T+365 SEK 3.82
- +1.0%Entry SEK 3.95 · Close at T+365 SEK 3.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Karl Karlsson: trading record in brief
Karl Karlsson discloses dealings in Newbury Pharmaceuticals AB to Finansinspektionen. We count 15 filings; the first trade dates from 11 January 2022 and the latest from 11 January 2024.
In open-market terms, that means 12 purchases worth €143k on one side and 1 sale worth €313k on the other. Taken together, the sales exceed the purchases by €170k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at no purchases and 1 sale.
A typical purchase (the median) is worth €3,948. Clusters matter here: 8 out of 11 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 11 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 55% of cases, with a median move of +57.8%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 11 January 2024 with an open-market sale (€313k) in Newbury Pharmaceuticals AB. The clock since the last published purchase (30 October 2023) now reads 1,105 days. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Karl Karlsson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,750,000 shares@ SEK 0.3671.6% of flowAktieISIN SE0015244884FI:csv-bf9ba87870a1a6e554a1
- 30,000 shares@ SEK 3.4350.6% of flowAktieISIN SE0015244884FI:csv-776bf0339f5e2e52ceb4Canonical exit: 28 Jan 2024 (T+90)
- 2,500 shares@ SEK 3.864.7% of flowAktieISIN SE0015244884FI:csv-a9e2eb68fa0ca6b6eb35Canonical exit: 28 Jan 2024 (T+90)
- 10,000 shares@ SEK 6.191.3% of flowAktieISIN SE0015244884FI:csv-b037b70737be0797826fCanonical exit: 19 Apr 2023 (T+90)
- 25,000 shares@ SEK 4.1222.2% of flowAktieISIN SE0015244884FI:csv-94089bc769a925ce9c3fCanonical exit: 6 Dec 2022 (T+90)
- 10,000 shares@ SEK 4.0221.8% of flowAktieISIN SE0015244884FI:csv-5fc6a6bba2da91d6e4f9Canonical exit: 5 Dec 2022 (T+90)
- 5,000 shares@ SEK 4.5412.3% of flowAktieISIN SE0015244884FI:csv-e73ba1970331276883d8Canonical exit: 30 Nov 2022 (T+90)
- 10,000 shares@ SEK 4.440.9% of flowAktieISIN SE0015244884FI:csv-7bf0b065247652d8eb71Canonical exit: 29 Nov 2022 (T+90)
- 10,000 shares@ SEK 7.5997.0% of flowAktieISIN SE0015244884FI:csv-760a8db869355267b5d4Canonical exit: 31 Aug 2022 (T+90)
- 2,000 shares@ SEK 9.7010.6% of flowAktieISIN SE0015244884FI:csv-967f49882229af524420Canonical exit: 30 May 2022 (T+90)
- 2,000 shares@ SEK 9.540.4% of flowAktieISIN SE0015244884FI:csv-43cc8c12fd7e39a711f3Canonical exit: 15 May 2022 (T+90)
- 3,846,154 shares0AktieISIN SE0015244884FI:csv-e8ab529cda4f69daf13b
- 76,924 shares@ SEK 13.0021.9% of flowAktieISIN SE0015244884FI:csv-458719b48cb52e8bb55eCanonical exit: 28 Apr 2022 (T+90)
- 3,846,154 shares0AktieISIN SE0015244884FI:csv-82d30b92317d7e67fb99
14 of 14 declarations